Elodie M Da Costa - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Elodie M Da Costa

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Cancer Journal (Sudbury, Mass.)|September 20, 2017

DNA Methylation-Targeted DrugsElodie M Da Costa, Gabrielle McInnes, Annie Beaudry, et al.

Molecular Cancer Therapeutics|December 17, 2016

Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer EpigenomeNoël J-M Raynal, Elodie M Da Costa, Justin T Lee, et al.

Journal of Experimental & Clinical Cancer Research : CR|June 15, 2019

Heart failure drug proscillaridin A targets MYC overexpressing leukemia through global loss of lysine acetylationElodie M Da Costa, Gregory Armaos, Gabrielle McInnes, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Cancer Journal (Sudbury, Mass.)|September 20, 2017

DNA Methylation-Targeted DrugsElodie M Da Costa, Gabrielle McInnes, Annie Beaudry, et al.

Molecular Cancer Therapeutics|December 17, 2016

Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer EpigenomeNoël J-M Raynal, Elodie M Da Costa, Justin T Lee, et al.

Journal of Experimental & Clinical Cancer Research : CR|June 15, 2019

Heart failure drug proscillaridin A targets MYC overexpressing leukemia through global loss of lysine acetylationElodie M Da Costa, Gregory Armaos, Gabrielle McInnes, et al.

Pageof 1